Carbapenem-Based Antibiotics Market, Global Outlook and Forecast 2022-2028

May 2022 | 61 pages | ID: C1DA18B7FCB6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Carbapenem-Based Antibiotics in Global, including the following market information:

Global Carbapenem-Based Antibiotics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Carbapenem-Based Antibiotics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Meropenem Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Carbapenem-Based Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec and Pfizer Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Carbapenem-Based Antibiotics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Carbapenem-Based Antibiotics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Carbapenem-Based Antibiotics Market Segment Percentages, by Type, 2021 (%)

• Meropenem
• Doripenemu
• Imipenem
• Tebipenemu
• Others

Global Carbapenem-Based Antibiotics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Carbapenem-Based Antibiotics Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies

Global Carbapenem-Based Antibiotics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Carbapenem-Based Antibiotics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Carbapenem-Based Antibiotics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Carbapenem-Based Antibiotics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ACS Dobfar S.p.A
• Iterum Therapeutics plc
• DAEWOONG PHARMACEUTICAL CO.,LTD
• Aurobindo Pharma Ltd
• Gland Pharma Limited
• Merck & Co., Inc.
• Sumitomo Dainippon Pharma Co., Ltd.
• Savior Lifetec
• Pfizer Inc.
• Spero Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Carbapenem-Based Antibiotics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Carbapenem-Based Antibiotics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CARBAPENEM-BASED ANTIBIOTICS OVERALL MARKET SIZE

2.1 Global Carbapenem-Based Antibiotics Market Size: 2021 VS 2028
2.2 Global Carbapenem-Based Antibiotics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Carbapenem-Based Antibiotics Players in Global Market
3.2 Top Global Carbapenem-Based Antibiotics Companies Ranked by Revenue
3.3 Global Carbapenem-Based Antibiotics Revenue by Companies
3.4 Top 3 and Top 5 Carbapenem-Based Antibiotics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Carbapenem-Based Antibiotics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Carbapenem-Based Antibiotics Players in Global Market
  3.6.1 List of Global Tier 1 Carbapenem-Based Antibiotics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Carbapenem-Based Antibiotics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Carbapenem-Based Antibiotics Market Size Markets, 2021 & 2028
  4.1.2 Meropenem
  4.1.3 Doripenemu
  4.1.4 Imipenem
  4.1.5 Tebipenemu
  4.1.6 Others
4.2 By Type - Global Carbapenem-Based Antibiotics Revenue & Forecasts
  4.2.1 By Type - Global Carbapenem-Based Antibiotics Revenue, 2017-2022
  4.2.2 By Type - Global Carbapenem-Based Antibiotics Revenue, 2023-2028
  4.2.3 By Type - Global Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Carbapenem-Based Antibiotics Market Size, 2021 & 2028
  5.1.2 Retail Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Hospital Pharmacies
5.2 By Application - Global Carbapenem-Based Antibiotics Revenue & Forecasts
  5.2.1 By Application - Global Carbapenem-Based Antibiotics Revenue, 2017-2022
  5.2.2 By Application - Global Carbapenem-Based Antibiotics Revenue, 2023-2028
  5.2.3 By Application - Global Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Carbapenem-Based Antibiotics Market Size, 2021 & 2028
6.2 By Region - Global Carbapenem-Based Antibiotics Revenue & Forecasts
  6.2.1 By Region - Global Carbapenem-Based Antibiotics Revenue, 2017-2022
  6.2.2 By Region - Global Carbapenem-Based Antibiotics Revenue, 2023-2028
  6.2.3 By Region - Global Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Carbapenem-Based Antibiotics Revenue, 2017-2028
  6.3.2 US Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.3.3 Canada Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.3.4 Mexico Carbapenem-Based Antibiotics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Carbapenem-Based Antibiotics Revenue, 2017-2028
  6.4.2 Germany Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.4.3 France Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.4.4 U.K. Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.4.5 Italy Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.4.6 Russia Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.4.7 Nordic Countries Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.4.8 Benelux Carbapenem-Based Antibiotics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Carbapenem-Based Antibiotics Revenue, 2017-2028
  6.5.2 China Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.5.3 Japan Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.5.4 South Korea Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.5.5 Southeast Asia Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.5.6 India Carbapenem-Based Antibiotics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Carbapenem-Based Antibiotics Revenue, 2017-2028
  6.6.2 Brazil Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.6.3 Argentina Carbapenem-Based Antibiotics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Carbapenem-Based Antibiotics Revenue, 2017-2028
  6.7.2 Turkey Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.7.3 Israel Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.7.4 Saudi Arabia Carbapenem-Based Antibiotics Market Size, 2017-2028
  6.7.5 UAE Carbapenem-Based Antibiotics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 ACS Dobfar S.p.A
  7.1.1 ACS Dobfar S.p.A Corporate Summary
  7.1.2 ACS Dobfar S.p.A Business Overview
  7.1.3 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Major Product Offerings
  7.1.4 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.1.5 ACS Dobfar S.p.A Key News
7.2 Iterum Therapeutics plc
  7.2.1 Iterum Therapeutics plc Corporate Summary
  7.2.2 Iterum Therapeutics plc Business Overview
  7.2.3 Iterum Therapeutics plc Carbapenem-Based Antibiotics Major Product Offerings
  7.2.4 Iterum Therapeutics plc Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.2.5 Iterum Therapeutics plc Key News
7.3 DAEWOONG PHARMACEUTICAL CO.,LTD
  7.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Corporate Summary
  7.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
  7.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Major Product Offerings
  7.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Key News
7.4 Aurobindo Pharma Ltd
  7.4.1 Aurobindo Pharma Ltd Corporate Summary
  7.4.2 Aurobindo Pharma Ltd Business Overview
  7.4.3 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Major Product Offerings
  7.4.4 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.4.5 Aurobindo Pharma Ltd Key News
7.5 Gland Pharma Limited
  7.5.1 Gland Pharma Limited Corporate Summary
  7.5.2 Gland Pharma Limited Business Overview
  7.5.3 Gland Pharma Limited Carbapenem-Based Antibiotics Major Product Offerings
  7.5.4 Gland Pharma Limited Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.5.5 Gland Pharma Limited Key News
7.6 Merck & Co., Inc.
  7.6.1 Merck & Co., Inc. Corporate Summary
  7.6.2 Merck & Co., Inc. Business Overview
  7.6.3 Merck & Co., Inc. Carbapenem-Based Antibiotics Major Product Offerings
  7.6.4 Merck & Co., Inc. Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.6.5 Merck & Co., Inc. Key News
7.7 Sumitomo Dainippon Pharma Co., Ltd.
  7.7.1 Sumitomo Dainippon Pharma Co., Ltd. Corporate Summary
  7.7.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
  7.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Major Product Offerings
  7.7.4 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.7.5 Sumitomo Dainippon Pharma Co., Ltd. Key News
7.8 Savior Lifetec
  7.8.1 Savior Lifetec Corporate Summary
  7.8.2 Savior Lifetec Business Overview
  7.8.3 Savior Lifetec Carbapenem-Based Antibiotics Major Product Offerings
  7.8.4 Savior Lifetec Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.8.5 Savior Lifetec Key News
7.9 Pfizer Inc.
  7.9.1 Pfizer Inc. Corporate Summary
  7.9.2 Pfizer Inc. Business Overview
  7.9.3 Pfizer Inc. Carbapenem-Based Antibiotics Major Product Offerings
  7.9.4 Pfizer Inc. Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Inc. Key News
7.10 Spero Therapeutics
  7.10.1 Spero Therapeutics Corporate Summary
  7.10.2 Spero Therapeutics Business Overview
  7.10.3 Spero Therapeutics Carbapenem-Based Antibiotics Major Product Offerings
  7.10.4 Spero Therapeutics Carbapenem-Based Antibiotics Revenue in Global Market (2017-2022)
  7.10.5 Spero Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Carbapenem-Based Antibiotics Market Opportunities & Trends in Global Market
Table 2. Carbapenem-Based Antibiotics Market Drivers in Global Market
Table 3. Carbapenem-Based Antibiotics Market Restraints in Global Market
Table 4. Key Players of Carbapenem-Based Antibiotics in Global Market
Table 5. Top Carbapenem-Based Antibiotics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Carbapenem-Based Antibiotics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Carbapenem-Based Antibiotics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Carbapenem-Based Antibiotics Product Type
Table 9. List of Global Tier 1 Carbapenem-Based Antibiotics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Carbapenem-Based Antibiotics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Carbapenem-Based Antibiotics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Carbapenem-Based Antibiotics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Carbapenem-Based Antibiotics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Carbapenem-Based Antibiotics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Carbapenem-Based Antibiotics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Carbapenem-Based Antibiotics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2023-2028
Table 30. ACS Dobfar S.p.A Corporate Summary
Table 31. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Product Offerings
Table 32. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 33. Iterum Therapeutics plc Corporate Summary
Table 34. Iterum Therapeutics plc Carbapenem-Based Antibiotics Product Offerings
Table 35. Iterum Therapeutics plc Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 36. DAEWOONG PHARMACEUTICAL CO.,LTD Corporate Summary
Table 37. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Product Offerings
Table 38. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 39. Aurobindo Pharma Ltd Corporate Summary
Table 40. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Product Offerings
Table 41. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 42. Gland Pharma Limited Corporate Summary
Table 43. Gland Pharma Limited Carbapenem-Based Antibiotics Product Offerings
Table 44. Gland Pharma Limited Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 45. Merck & Co., Inc. Corporate Summary
Table 46. Merck & Co., Inc. Carbapenem-Based Antibiotics Product Offerings
Table 47. Merck & Co., Inc. Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 48. Sumitomo Dainippon Pharma Co., Ltd. Corporate Summary
Table 49. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Product Offerings
Table 50. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 51. Savior Lifetec Corporate Summary
Table 52. Savior Lifetec Carbapenem-Based Antibiotics Product Offerings
Table 53. Savior Lifetec Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Inc. Corporate Summary
Table 55. Pfizer Inc. Carbapenem-Based Antibiotics Product Offerings
Table 56. Pfizer Inc. Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)
Table 57. Spero Therapeutics Corporate Summary
Table 58. Spero Therapeutics Carbapenem-Based Antibiotics Product Offerings
Table 59. Spero Therapeutics Carbapenem-Based Antibiotics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Carbapenem-Based Antibiotics Segment by Type in 2021
Figure 2. Carbapenem-Based Antibiotics Segment by Application in 2021
Figure 3. Global Carbapenem-Based Antibiotics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Carbapenem-Based Antibiotics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Carbapenem-Based Antibiotics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Carbapenem-Based Antibiotics Revenue in 2021
Figure 8. By Type - Global Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
Figure 12. US Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
Figure 16. Germany Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 17. France Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
Figure 24. China Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 28. India Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
Figure 30. Brazil Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Carbapenem-Based Antibiotics Revenue Market Share, 2017-2028
Figure 33. Turkey Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Carbapenem-Based Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 37. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Iterum Therapeutics plc Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Gland Pharma Limited Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck & Co., Inc. Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Savior Lifetec Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Inc. Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Spero Therapeutics Carbapenem-Based Antibiotics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)